Mitochondrial Dysfunction and Neurodegenerative Disorders: Role of Nutritional Supplementation

22Citations
Citations of this article
42Readers
Mendeley users who have this article in their library.

Abstract

Mitochondrial dysfunction has been implicated in the pathogenesis of a number of neurodegenerative disorders, including Parkinson’s disease, Alzheimer’s disease, amyotrophic lateral sclerosis, multisystem atrophy, and progressive supranuclear palsy. This article is concerned specifically with mitochondrial dysfunction as defined by reduced capacity for ATP production, the role of depleted levels of key nutritionally related metabolites, and the potential benefit of supplementation with specific nutrients of relevance to normal mitochondrial function in the above neurodegenerative disorders. The article provides a rationale for a combination of CoQ10, B-vitamins/NADH, L-carnitine, vitamin D, and alpha-lipoic acid for the treatment of the above neurodegenerative disorders.

Cite

CITATION STYLE

APA

Mantle, D., & Hargreaves, I. P. (2022, October 1). Mitochondrial Dysfunction and Neurodegenerative Disorders: Role of Nutritional Supplementation. International Journal of Molecular Sciences. MDPI. https://doi.org/10.3390/ijms232012603

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free